Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis - Top-Institutions - MDSpire

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

  • By

  • Konstantinos Pamporis

  • Paschalis Karakasis

  • Marios Sagris

  • Panagiotis Theofilis

  • Nikias Milaras

  • Antonia Pantelidaki

  • Iordanis Mourouzis

  • Nikolaos Fragakis

  • Konstantinos Vlachos

  • Athanasios Kordalis

  • Dimitrios Tsiachris

  • March 7, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Electrophysiology
    • Preventive Cardiology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Electrophysiology
    • Cardiac Arrhythmia

  • #3

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Electrophysiology
    • Preventive Cardiology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Electrophysiology
    • Clinical Research

  • #5

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Cardiology
    • Electrophysiology
    • Biomedical Research

Original Source(s)

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

  • by Konstantinos Pamporis, Paschalis Karakasis, Marios Sagris, Panagiotis Theofilis, Nikias Milaras, Antonia Pantelidaki, Iordanis Mourouzis, Nikolaos Fragakis, Konstantinos Vlachos, Athanasios Kordalis, Dimitrios Tsiachris

  • March 7, 2025

Related Content

Case Report: Selective metal cell excision during open TAVR implantation preserves coronary access while maintaining valve integrity and function

Transcriptomic signatures and immune microenvironment of acute rejection after heart transplantation: an integrated bioinformatics analysis

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.